308 related articles for article (PubMed ID: 24157405)
81. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
[TBL] [Abstract][Full Text] [Related]
82. Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis.
Alcaide SM; Diana CAF; Herrero JC; Vegue LB; Perez AV; Arce ES; Sapiña JBB; Noguera PJG; Caravajal JMG
Arch Gynecol Obstet; 2022 Dec; 306(6):2123-2131. PubMed ID: 35503378
[TBL] [Abstract][Full Text] [Related]
83. Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views.
O'Brien MA; Tsao M; Cornacchi SD; Hodgson N; Reid S; Simunovic M; Mukherjee SD; Strang B; Thabane L; Lovrics PJ
Breast; 2016 Oct; 29():126-31. PubMed ID: 27484016
[TBL] [Abstract][Full Text] [Related]
84. Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.
Bassi KK; Seenu V; Ballehaninna UK; Parshad R; Chumber S; Dhar A; Gupta SD; Kumar R; Srivastava A
Indian J Cancer; 2006; 43(3):103-9. PubMed ID: 17065767
[TBL] [Abstract][Full Text] [Related]
85. Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients.
Lv L; Ma RM; Yang F; Zhang XH; Huang DP
Int J Clin Exp Pathol; 2015; 8(9):11171-7. PubMed ID: 26617838
[TBL] [Abstract][Full Text] [Related]
86. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
Farley C; Bassett R; Meric-Bernstam F; Bedrosian I; Caudle A; DeSnyder S; Hunt K; Kuerer H; Singh P; Sun S; Tamirisa N; Teshome M; Hwang RF
Ann Surg Oncol; 2023 Dec; 30(13):8327-8334. PubMed ID: 37670121
[TBL] [Abstract][Full Text] [Related]
87. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
[TBL] [Abstract][Full Text] [Related]
88. Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
Riedel F; Heil J; Feisst M; Moderow M; von Au A; Domschke C; Michel L; Schaefgen B; Golatta M; Hennigs A
Breast Cancer Res Treat; 2020 Nov; 184(2):627-636. PubMed ID: 32816190
[TBL] [Abstract][Full Text] [Related]
89. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
[TBL] [Abstract][Full Text] [Related]
90. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
[TBL] [Abstract][Full Text] [Related]
91. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
Reynolds C; Mick R; Donohue JH; Grant CS; Farley DR; Callans LS; Orel SG; Keeney GL; Lawton TJ; Czerniecki BJ
J Clin Oncol; 1999 Jun; 17(6):1720-6. PubMed ID: 10561208
[TBL] [Abstract][Full Text] [Related]
92. Lymphovascular invasion is a significant risk factor for non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node (SLN)-positive breast cancer: a cross-sectional study.
Wei C; Deng Y; Wei S; Huang Z; Xie Y; Xu J; Dong L; Zou Q; Yang J
World J Surg Oncol; 2023 Dec; 21(1):386. PubMed ID: 38097994
[TBL] [Abstract][Full Text] [Related]
93. [Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients].
Jiao D; Qiao J; Lu Z; Li L; Zhang H; Liu H; Cui S; Liu Z
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):198-201. PubMed ID: 24785280
[TBL] [Abstract][Full Text] [Related]
94. Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?
Williams AD; Ruth K; Shaikh SS; Vasigh M; Pronovost MT; Aggon AA; Porpiglia AS; Bleicher RJ
Cancer; 2024 Apr; 130(7):1052-1060. PubMed ID: 38018862
[TBL] [Abstract][Full Text] [Related]
95. Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.
Piñero-Madrona A; Ruiz-Merino G; Bernet L; Miguel-Martínez B; Vicente-García F; Viguri-Díaz MA; Giménez-Climent J
Breast; 2014 Dec; 23(6):859-64. PubMed ID: 25283682
[TBL] [Abstract][Full Text] [Related]
96. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer.
Leonard LD; de Araujo TB; Quinn C; Thomas MB; Beaty L; Mott NM; Colborn K; Heelan AA; Tevis SEA; Christian N; Arhendt G; Gleisner AL
Ann Surg Oncol; 2023 Sep; 30(9):5692-5702. PubMed ID: 37326811
[TBL] [Abstract][Full Text] [Related]
97. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
[TBL] [Abstract][Full Text] [Related]
98. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer.
Goyal A; Douglas-Jones AG; Newcombe RG; Mansel RE
Breast J; 2005; 11(3):188-94. PubMed ID: 15871704
[TBL] [Abstract][Full Text] [Related]
99. How much does axillary ultrasound contribute in women undergoing breast-conserving surgery with no palpable axillary nodes?
Preda T; McGrath R; Bingham J; Fawcett A; O'Dea C; Bochner M; Gill PG; Kollias J
ANZ J Surg; 2020 Jun; 90(6):1146-1150. PubMed ID: 31957192
[TBL] [Abstract][Full Text] [Related]
100. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
Mittendorf EA; Sahin AA; Tucker SL; Meric-Bernstam F; Yi M; Nayeemuddin KM; Babiera GV; Ross MI; Feig BW; Kuerer HM; Hunt KK
Ann Surg Oncol; 2008 Dec; 15(12):3369-77. PubMed ID: 18815841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
